Annovis Bio, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Annovis Bio, Inc. reported Cash And Cash Equivalents At Carrying Value of $19.53 million for the year ending 2025.

  • Annovis Bio, Inc. showed an increase of +85.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Annovis Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 13, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2019 to 2025), Annovis Bio, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 1,051,156.1%.
  • Historical annual values: Fiscal year 2025: $19.53 million | Fiscal year 2024: $10.55 million | Fiscal year 2023: $5.75 million | Fiscal year 2022: $28.38 million | Fiscal year 2022: $31.99 million | Fiscal year 2022: $35.97 million | Fiscal year 2022: $42.67 million | Fiscal year 2021: $45.69 million | Fiscal year 2020: $8.07 million | Fiscal year 2019: $1.9 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: